» Articles » PMID: 6895622

Polymorphic 4-hydroxylation of Debrisoquine in Chronic Discoid Psoriasis

Overview
Specialty Pharmacology
Date 1981 Jan 1
PMID 6895622
Authors
Affiliations
Soon will be listed here.
References
1.
Danhof M, Breimer D . Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers. Br J Clin Pharmacol. 1979; 8(6):529-37. PMC: 1429894. DOI: 10.1111/j.1365-2125.1979.tb01040.x. View

2.
Chapman P, Keys B, Rawlins M, Moss C, Shuster S . Antipyrine clearance in psoriasis. Br Med J (Clin Res Ed). 1981; 282(6257):20-1. PMC: 1503795. DOI: 10.1136/bmj.282.6257.20. View

3.
Shuster S, Rawlins M, Chapman P, Rogers S . Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis. Br J Dermatol. 1980; 103(1):23-6. DOI: 10.1111/j.1365-2133.1980.tb15833.x. View

4.
Chapman P, Rawlins M, Shuster S . Activity of aryl hydrocarbon hydroxylase in psoriatic skin. Lancet. 1979; 1(8111):297-8. DOI: 10.1016/s0140-6736(79)90706-2. View

5.
Chapman P, Rawlins M, Shuster S . The activity of aryl hydrocarbon hydroxylase in adult human skin. Br J Clin Pharmacol. 1979; 7(5):499-503. PMC: 1429572. DOI: 10.1111/j.1365-2125.1979.tb00993.x. View